GSK2245035 is a potent and selective intranasal TLR7 agonist that preferentially induces Type-1 interferon (IFNalpha) over TNFalpha. It is utilized in immunology research to study antiviral responses and allergic inflammation, having been shown to inhibit Th2 cytokine production in human cell-based assays.
Molecular Weight:
390.52
CAS Number:
[1207629-49-9]
Formula:
C20H34N6O2
Target:
Others,TNF,IFNAR,TLR
* VAT and and shipping costs not included. Errors and price changes excepted
